CAS 1394157-34-6
:Formula:C20H25FN3O9P
InChI:InChI=1S/C20H25FN3O9P/c1-12(17(27)30-3)23-34(29,33-13-7-5-4-6-8-13)31-11-14-16(26)20(2,21)18(32-14)24-10-9-15(25)22-19(24)28/h4-10,12,14,16,18,26H,11H2,1-3H3,(H,23,29)(H,22,25,28)/t12-,14+,16+,18+,20+,34-/m0/s1
InChI key:SASYBZIIPQSWBV-ZWXZMKCMSA-N
SMILES:C[C@@H](C(=O)OC)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 9 products.
Sofosbuvir impurity N
CAS:Sofosbuvir impurity N is an diastereoisomer of Sofosbuvir.Sofosbuvir is an HCV RNA replication inhibitor, with potent anti-hepatitis C virus activity.Formula:C20H25FN3O9PPurity:98%Color and Shape:SolidMolecular weight:501.404N-[[P(S),2′R]-2′-Deoxy-2′-fluoro-2′-methyl-P-phenyl-5′-uridylyl]-L-alanine Methyl Ester
CAS:Controlled ProductFormula:C20H25FN3O9PColor and Shape:NeatMolecular weight:501.399Sofosbuvir impurity N
CAS:Sofosbuvir impurity N is a chemical impurity found as a byproduct in the synthesis of sofosbuvir, a nucleotide analog used as an antiviral drug. Its origin is directly linked to the complex chemical processes involved in producing the active pharmaceutical ingredient. This impurity is specifically identified and analyzed to ensure the purity and efficacy of the sofosbuvir drug. Impurities like these are of significant interest in pharmaceutical development, as they provide insights into the synthetic pathways and potential degradation products.
Formula:C20H25FN3O9PPurity:Min. 95%Molecular weight:501.4 g/mol
![N-[[P(S),2′R]-2′-Deoxy-2′-fluoro-2′-methyl-P-phenyl-5′-uridylyl]-L-alanine Methyl Ester](https://static.cymitquimica.com/products/TR/thumb/D422270.jpg)
